Stromal-Cell-Derived Factor-1 (SDF-1)/CXCL12 as Potential Target of Therapeutic Angiogenesis in Critical Leg Ischaemia
In the Western world, peripheral vascular disease (PVD) has a high prevalence with high morbidity and mortality. In a large percentage of these patients, lower limb amputation is still required. Studies of ischaemic skeletal muscle disclosed evidence of endogenous angiogenesis and adaptive skeletal...
Main Authors: | Teik K. Ho, X. Shiwen, D. Abraham, J. Tsui, D. Baker |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Cardiology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2012/143209 |
Similar Items
-
CXCL12/SDF-1 and CXCR4
by: Takashi eNagasawa
Published: (2015-06-01) -
Stromal Derived Factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis
by: Reckamp Karen, et al.
Published: (2006-11-01) -
Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling.
by: Jason A Wojcechowskyj, et al.
Published: (2011-01-01) -
CXCL12/SDF-1 facilitates optic nerve regeneration
by: Annemarie Heskamp, et al.
Published: (2013-07-01) -
Concentration of stromal cell‐derived factor‐1 (SDF‐1/CXCL12) in the follicular fluid is associated with blastocyst development
by: Akemi Nishigaki, et al.
Published: (2019-04-01)